We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline's (GSK) drug Wellbutrin XR has received a marketing license in the Netherlands, making it the first antidepressant of its kind to be approved in Europe, the company announced.
Multiple patent infringement lawsuits filed in federal court by Teva Pharmaceutical against competitors gearing up to market their own generic versions of Zoloft could jeopardize their efforts, legal sources say.
The FDA has issued a draft guidance with recommendations on how blood product manufacturers can apply for licenses to use placental or umbilical cord blood for treatments for hematological malignancies.
An FDA advisory committee is recommending that the agency fundamentally change the way it tests new contraceptives to focus on comparative drug studies.
GS1 EPCglobal, the nonprofit standards organization dedicated to promoting worldwide adoption of electronic product codes (EPCs) for supply-chain excellence, said it has ratified the open Electronic Pedigree Document specification.
Twenty-two prescription medicines have been added to the Kmart Pharmacy discount program that offers a 90-day supply of generic drugs for a flat rate of $15, Sears Holdings announced.
Pfizer is making major changes in the way the company is run in an effort to drive down costs, increase revenue and enhance innovation, Pfizer announced at a meeting of its senior staff.
Biotech company Synosis will acquire five drug candidates that target the central nervous system as part of a new partnership with Roche, Synosis announced.
Two drugs used to treat Parkinson's disease may increase the risk for heart valve damage, according to two studies published in the New England Journal of Medicine (NEJM).